Evidence map›Paper›PMID 28086833›Full record

ArticleBMC cancer2017

Delta-like 4/Notch signaling promotes Apc

Marina Badenes, Alexandre Trindade, Hugo Pissarra, Luís Lopes-da-Costa, António Duarte

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMC cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Whole Exome Sequencing IdentifiesInternational journal of molecular sciences · 2021
    Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. The application of ApcJournal of cancer research and clinical oncology · 2019
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Marina BadenesCentro Interdisciplinar de Investigação em Sanidade Animal (CIISA), University of Lisbon, Lisbon, Portugal.
Alexandre TrindadeCentro Interdisciplinar de Investigação em Sanidade Animal (CIISA), University of Lisbon, Lisbon, Portugal.
Hugo PissarraCentro Interdisciplinar de Investigação em Sanidade Animal (CIISA), University of Lisbon, Lisbon, Portugal.
Luís Lopes-da-CostaCentro Interdisciplinar de Investigação em Sanidade Animal (CIISA), University of Lisbon, Lisbon, Portugal.
António DuarteCentro Interdisciplinar de Investigação em Sanidade Animal (CIISA), University of Lisbon, Lisbon, Portugal. aduarte@fmv.ulisboa.pt.ORCID 0000-0002-9255-3635
University of Lisbon · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDelta like 4 (Dll4)/Notch signaling is a key regulator of tumor angiogenesis. Additionally, the role of Dll4 has been studied on tumor stem cells. However, as these cells are implicated in tumor angiogenesis, it is conceivable that the effect of Dll4 on these cells may be a consequence of its angiogenic function. Our aim was to evaluate the expression and dissect the functions of Dll4 in the Apc

methodsWe evaluated the protein expression pattern of Dll4 and other Notch members in the Apc

resultsAll Notch pathway members were present in the normal small and large intestine and in the adenomas of the same regions. Dll4, all Notch receptors and Hes1 expression seemed upregulated in the tumors, with some regional differences. The same members and Hes5, instead of Hes1, presented ectopic expression in the tumor parenchyma. Dll4 expression was most pronounced in the tumor cells but it was also present in the tumor blood vessels and in other stromal cells. Ubiquitous and endothelial-specific Dll4 deletion led to an equivalent reduction of tumor growth because of a similarly marked tumoral angiogenic phenotype promoting non-productive vasculature and consequently hypoxia and apoptosis. The ubiquitous Dll4 inhibition led to a stronger decrease of tumor multiplicity than the endothelial-specific deletion by further reducing tumor proliferation and tumor stem cell density through upregulation of the cyclin-dependent kinase inhibitors 1C and 1B and downregulation of Myc, Cyclin D1 and D2 independently of β-catenin activation. This phenotype was associated to the observed increased epithelial differentiation deviated towards the secretory lineages by Atoh1 and Klf4 upregulation only in the ubiquitous Dll4 mutants.

conclusionsDll4 seems to promote Apc

Indexed as

Adaptor Proteins, Signal TransducingAdenomatous Polyposis Coli ProteinAnimalsbeta CateninCalcium-Binding ProteinsCell ProliferationCell Transformation, NeoplasticCyclin-Dependent KinasesEndothelial CellsIntercellular Signaling Peptides and ProteinsIntracellular Signaling Peptides and ProteinsKruppel-Like Factor 4MaleMembrane ProteinsMiceMice, Inbred C57BLAdaptor Proteins, Signal TransducingAdenomatous Polyposis Coli Proteinadenomatous polyposis coli protein, mousebeta CateninCalcium-Binding ProteinsCyclin-Dependent KinasesDLL4 protein, mouseIntercellular Signaling Peptides and ProteinsIntracellular Signaling Peptides and ProteinsKlf4 protein, mouseKruppel-Like Factor 4Membrane ProteinsReceptors, NotchAngiogenesisApc Min/+ mouseDll4Endothelial-specific knockoutNotch expressionTumor stem cellsUbiquitous knockout

Identifiers

PMID28086833
PMCPMC5237288
OpenAlexW2577311335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.